Xemilofiban Hydrochloride

N/A

Report date: 2022/05/25 17:33:54
NME

Base Information

Drug NameXemilofiban Hydrochloride
Drug Alias Namexemilofibanum珍米洛非班塞米非班SC-5468 4 HydrochlorideSC-54684A (HCl) +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosisMyocardial InfarctionAngina, Unstable
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial InfarctionAngina, Unstable

Other Information

ATC CodeN/A
Related LinksKEGG